Marksans Pharma Ltd.

₹329

- 1.45 (-0.44%)

04:01 pm - close price

BSE: MARKSANS

NSE: MARKSANS

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 9.22Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.22Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.10Good: 20

✅

Current Ratio

Bad: 1Current: 5.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.77Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 9.22Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.22Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.10Good: 20

✅

Current Ratio

Bad: 1Current: 5.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.77Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	531.24	586.13	560.01	590.62
Expenditure+	417.29	453.11	450.37	462.18
Other Income+	19.00	4.80	16.53	14.95
Operating Profit	113.95	133.02	109.64	128.44
Interest	1.63	3.16	4.84	2.92
Depreciation and Amortization	17.55	22.00	21.05	20.44
Profit Before Tax	113.77	112.66	100.28	120.02
Tax+	29.92	29.69	22.63	30.95
Net Profit	83.85	82.97	77.64	89.07

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	14908.39	18521.39	21774.07	26228.45	29509.38
Operational Expenses+	12319.59	15128.18	17188.30	20901.61	23501.59
Operating Profit	2588.80	3393.21	4585.77	5326.84	6007.79
Other Income	418.53	593.13	504.22	663.29	825.33
OPM %	17.36	18.32	21.06	20.31	20.36
Depreciation and Amortisation	447.76	518.53	742.70	833.86	986.32
Interest	84.46	91.28	112.03	116.60	241.25
Profit Before Tax	2475.11	3376.53	4235.26	5039.67	5605.55
Tax	606.89	726.65	1082.03	1200.40	1374.57
Net Profit	1845.69	2663.08	3137.00	3805.75	4179.00

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	16601.08	21903.89	26809.53	32396.32	38479.37
Liabilities+	16601.08	21903.89	26809.53	32396.32	38479.37

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	992.57	2374.12	2304.07	2066.64	4581.25
Cash from Investing Activity	-843.91	-2592.12	-1408.40	-490.09	-2482.67
Cash from Financing Activity	795.11	1978.29	-687.27	-651.46	-709.28
Net Cash Flow	943.77	1760.29	208.40	925.09	1389.30
Opening Cash & Cash Equivalents	1120.29	2064.06	3824.37	4032.77	4957.86
Closing Cash & Cash Equivalents	2064.06	3824.37	4032.77	4957.86	6341.37

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.85
Public+	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.15
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	246635	246279	255153	265788	256221	257273	259813	248845	235500	254699

Corporate Actions

219 events in the last 3 years

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	14908.39	18521.39	21774.07	26228.45	29509.38
Operational Expenses+	12319.59	15128.18	17188.30	20901.61	23501.59
Operating Profit	2588.80	3393.21	4585.77	5326.84	6007.79
Other Income	418.53	593.13	504.22	663.29	825.33
OPM %	17.36	18.32	21.06	20.31	20.36
Depreciation and Amortisation	447.76	518.53	742.70	833.86	986.32
Interest	84.46	91.28	112.03	116.60	241.25
Profit Before Tax	2475.11	3376.53	4235.26	5039.67	5605.55
Tax	606.89	726.65	1082.03	1200.40	1374.57
Net Profit	1845.69	2663.08	3137.00	3805.75	4179.00

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	992.57	2374.12	2304.07	2066.64	4581.25
Cash from Investing Activity	-843.91	-2592.12	-1408.40	-490.09	-2482.67
Cash from Financing Activity	795.11	1978.29	-687.27	-651.46	-709.28
Net Cash Flow	943.77	1760.29	208.40	925.09	1389.30
Opening Cash & Cash Equivalents	1120.29	2064.06	3824.37	4032.77	4957.86
Closing Cash & Cash Equivalents	2064.06	3824.37	4032.77	4957.86	6341.37

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	531.24	586.13	560.01	590.62
Expenditure+	417.29	453.11	450.37	462.18
Other Income+	19.00	4.80	16.53	14.95
Operating Profit	113.95	133.02	109.64	128.44
Interest	1.63	3.16	4.84	2.92
Depreciation and Amortization	17.55	22.00	21.05	20.44
Profit Before Tax	113.77	112.66	100.28	120.02
Tax+	29.92	29.69	22.63	30.95
Net Profit	83.85	82.97	77.64	89.07

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.87	43.85
Public+	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.13	56.15
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	246635	246279	255153	265788	256221	257273	259813	248845	235500	254699

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	16601.08	21903.89	26809.53	32396.32	38479.37
Liabilities+	16601.08	21903.89	26809.53	32396.32	38479.37

Ratios

Reported EPS

Bad: 2Current: 9.22Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.22Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.10Good: 20

✅

Current Ratio

Bad: 1Current: 5.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.77Good: 0.5

🟡

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 9.22Good: 5

✅

Adjusted EPS

Bad: 3Current: 9.22Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.10Good: 20

✅

Current Ratio

Bad: 1Current: 5.17Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 15.31Good: 15

✅

Debt to Total Assets

Bad: 1Current: 0.77Good: 0.5

🟡

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Marksans Pharma Ltd.

₹329

- 1.45 (-0.44%)

04:01 pm - close price

BSE: MARKSANS

NSE: MARKSANS

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

219 events in the last 3 years